Stimuli‐Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy

Cancer immunotherapy has achieved promising clinical progress over the recent years for its potential to treat metastatic tumors and inhibit their recurrences effectively. However, low patient response rates and dose‐limiting toxicity remain as major dilemmas for immunotherapy. Stimuli‐responsive na...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jin, Lin, Yandai, Lin, Zhe, Wei, Qi, Qian, Jiaqi, Ruan, Renjie, Jiang, Xiancai, Hou, Linxi, Song, Jibin, Ding, Jianxun, Yang, Huanghao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844476/
https://www.ncbi.nlm.nih.gov/pubmed/34927373
http://dx.doi.org/10.1002/advs.202103444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844476/
https://www.ncbi.nlm.nih.gov/pubmed/34927373
http://dx.doi.org/10.1002/advs.202103444

Ejemplares similares